Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognition
Published version of a preprint
The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
The CRL4 CRBN E3 ubiquitin ligase is the target of molecular glue degrader compounds that reprogram ligase specificity to induce the degradation of clinically relevant neosubstrate proteins. Known cereblon (CRBN) neosubstrates share a generalizable β-hairpin G-loop recognition motif that allows for the systematic exploration of the CRBN target space. Computational mining approaches using structure- and surface-based matchmaking algorithms predict more than 1600 CRBN-compatible G-loop proteins across the human proteome, including the newly discovered helical G-loop motif, and identify the noncanonical neosubstrate binding mode of VAV1 that engages CRBN through a molecular surface mimicry mechanism. This work broadens the CRBN target space, redefines rules for neosubstrate recognition, and establishes a platform for the elimination of challenging drug targets by repurposing CRL4 CRBN through next-generation molecular glue degraders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The compound-mediated interface between CRBN and KAT2ANTD not only lacks a G-loop structural motif but also does not contain a structural mimic of the canonical motif as seen in VAV1 (11).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [11]
In the citing paper
“We found that KAT2ANTD buries a substantial portion of both the CRBNNTD and CRBNCTD, forming a broad PPI that is distinct from the more hotspot-driven interfaces created by the G-loop neo-substrates (e.g., IKZF1(45), GSPT1(40)), the G-loop mimetic (VAV1(11)), and the non-G-loop (G3BP2(14)) (Fig 3F).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [11]
In the citing paper
“together these results show that the targetable universe of proteins degradable by CRBN-recruiting MGs is not limited to POIs that contain the G-loop degron motif (4), or its structural mimic (11).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [11]
In the citing paper
“While targets with G-loop-like motifs have only sampled a fraction of this PPI hotspot on the CRBN CULT domain25 (Fig. 5), the G3BP2 binding mode demonstrates how engagement of a separate region of the hotspot bypasses previous requirements for target engagement.”
From Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicry (2026) · cites this paper as [25]
In the citing paper
“Strikingly, G3BP2 lacks key contacts with the CRBN CULT domain commonly involved in neosubstrate recruitment25–28, which distinguishes the binding mode of G3BP2 from other structurally characterized CRBN targets (Fig. 5a–d and Extended Data Fig. 10).”
From Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicry (2026) · cites this paper as [25]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320
ColabFold - Making protein folding accessible to all
Mirdita, M., Schütze, K., Moriwaki, Y., Heo, L., Ovchinnikov, S., & Steinegger, M. (2021) · doi:10.1101/2021.08.15.456425 · Cited by 9,391
Liebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., et al. (2019) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798319011471 · Cited by 7,953
Pfam: The protein families database in 2021
Mistry, J., Chuguransky, S., Williams, L., Qureshi, M., Salazar, G. A., Sonnhammer, E. L. L., Tosatto, S. C. E., Paladin, L., Raj, S., Richardson, L. J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa913 · Cited by 7,452
How good are my data and what is the resolution?
Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,697
Improvements to the APBS biomolecular solvation software suite
Jurrus, E., Engel, D., Star, K., Monson, K., Brandi, J., Felberg, L. E., Brookes, D. H., Wilson, L., Chen, J., Liles, K., et al. (2018) · Protein Science · doi:10.1002/pro.3280 · Cited by 2,405
Paysan-Lafosse, T., Blum, M., Chuguransky, S., Grego, T., Pinto, B. L., Salazar, G. A., Bileschi, M. L., Bork, P., Bridge, A., Colwell, L., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac993 · Cited by 2,399
Research works printed but not linked: 1
- O. S. Smart, G. Bricogne, Multifaceted Roles of Crystallography in Modern Drug Discovery, NATO Science for Peace and Security Series (Springer, 2015), pp. 165–181.
Cited by
Items 101–111 of 111
Chemical probes for Alzheimer’s disease targets
Aiken, S., Zarganes‐Tzitzikas, T., & Brennan, P. E. (2026) · Essays in Biochemistry · doi:10.1042/ebc20260014
Reprogramming VHL with molecular glues enables selective degradation of caspase-2Preprint
Hu, J., Deng, W., Ou, S., Golkar, A., Inglis, A., Smither, K., Li, S., Chen, K., Cho, K. F., Bae, S. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.12.744529
Self-citationA scalable platform to discover and characterize substrates of molecular glue degraders
(2026) · Nature Biotechnology · doi:10.1038/s41587-026-03256-4
Evolution of a Synthetic Strategy toward Highly Substituted Isoindolinone Glutarimide Fragments
Tam, A. T., Hong, A. Y., Chang, Y.-H., Timmerman, J. C., Pompeo, M., Gilbert, R. D., Zhang, H., & Han, C. (2026) · Organic Process Research & Development · doi:10.1021/acs.oprd.6c00316
Brennan, P. J., Guo, R., Ordureau, A., Singleton, S. E., Li, M., Halaç, F. A., Chang, C. H., Yu-Liao, L., Deane, C. M., Houk, K. N., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c14185
Molecular Glue Degraders in Early Development for Cancer Therapy
Özdemir, E. S., Jang, H., Keskin, O., Gürsoy, A., & Nussinov, R. (2026) · Medicinal Research Reviews · doi:10.1002/med.70104 · Cited by 1
L013 promotes NRF2 degradation in NRFA-subtype esophageal squamous cell carcinoma
Yu, X., Wu, Y., Sun, X., Han, R., Cai, Y., Zeng, W., Li, Y., Wang, Y., Zhao, Y., Rao, Y., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.103046
Cell type–selective targeting by heterobifunctional protein binders via in-cell enrichment
Bulldan, A., Zheng, M., Meyners, C., Purder, P. L., Krieger, J., Dreizler, J. K., Geiger, T. M., Repity, M. L., Lein, M. H., Quist-Løkken, I., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77460-w · Cited by 3
Molecular glues: Recent advances in cereblon substrate identification and mechanistic insights
Guan, Q., Shi, X., Yang, Q., Jiang, X., Liu, X., & Zhan, P. (2026) · Smart Molecules · doi:10.1002/smo2.70112
Fitness criteria for PROTACs as chemical probes: principles and applications
Sturbaut, M., & Ciulli, A. (2026) · Essays in Biochemistry · doi:10.1042/ebc20260006 · Cited by 1
Chen, S., Solazzo, R., Fouché, M., ROTH, H. ‐., Dittrich, B., & Riniker, S. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c12127
Metadata
- Authors
- Petzold, G., Gainza, P., Annunziato, S., Lamberto, I., Trenh, P., McAllister, L. A., DeMarco, B., Schwander, L., Bunker, R. D., Zlotosch, M., SriRamaratnam, R., Gilberto, S., Langousis, G., Donckele, E. J., Quan, C., Strande, V., De Donatis, G. M., Alabi, S. B., Alers, J., Matysik, M., Staehly, C., Dubois, A., Osmont, A., Garskovas, M., Lyon, D., Wiedmer, L., Oleinikovas, V., Lieberherr, R., Rubin, N. T., Lam, D. T., Lucas, X., Liardo, E., Widlund, N. I., Ritzén, A., Caceres, R. M., Vigil, D., Tsai, J., Wallace, O., Peluso, M., Sadok, A., Tiedt, R., Paterson, A. M., Zarayskiy, V., Fasching, B., Bonenfant, D., Warmuth, M., Castle, J. C., & Townson, S. A.
- Affiliations
- Boston Foundation (US)
- Monte Rosa Therapeutics Inc, Boston, MA, USA.
- Corresponding author
- Petzold, Georg
- Castle, John C.
- Townson, Sharon A.
- ORCID
- Petzold, Georg
- Gainza, Pablo
- Annunziato, Stefano
- Trenh, Peter
- McAllister, Laura A.
- Bunker, Richard D.
- SriRamaratnam, Rohitha
- Gilberto, Samuel
- Langousis, Gerasimos
- Donckele, Etienne J.
- Quan, Chao
- Alabi, Shanique B.
- Matysik, Michelle
- Lyon, David
- Oleinikovas, Vladimiras
- Lieberherr, Raphael
- Lucas, Xavier
- Ritzén, Andreas
- Caceres, Ramon Miguel
- Tsai, Jennifer
- Wallace, Owen
- Peluso, Marisa
- Sadok, Amine
- Tiedt, Ralph
- Fasching, Bernhard
- Bonenfant, Debora
- Castle, John C.
- Townson, Sharon A.
- Venue
- Science
- Published
- 2025-07-03
- Volume
- 389
- Issue
- 6755
- Pages
- eadt6736-eadt6736
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4411983851
- Semantic Scholar
- 4bb4e874249f92d431945f892817b0fe43714a19
- Cited by
- 117
- References
- 73
- Citations by year
- 2026: 73 · 2025: 43
- FWCI
- 34.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- molecular glues, Vav1, protein degradation
- MeSH terms
- Humans, Protein Binding, Substrate Specificity, Molecular Mimicry, Amino Acid Motifs, Ubiquitin-Protein Ligases, Adaptor Proteins, Signal Transducing, Data Mining, Drug Repositioning, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.